ES2019935B3 - Derivado de 14-hidroxieritromicina y metodo para obtenerlo. - Google Patents

Derivado de 14-hidroxieritromicina y metodo para obtenerlo.

Info

Publication number
ES2019935B3
ES2019935B3 ES87303799T ES87303799T ES2019935B3 ES 2019935 B3 ES2019935 B3 ES 2019935B3 ES 87303799 T ES87303799 T ES 87303799T ES 87303799 T ES87303799 T ES 87303799T ES 2019935 B3 ES2019935 B3 ES 2019935B3
Authority
ES
Spain
Prior art keywords
hydroxierythromycin
derived
methylerythromycin
griseo
cultivated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87303799T
Other languages
English (en)
Inventor
Joji Sasaki
Kazutoshi Mizoue
Takashi Adachi
Takatoshi Nagate
Shigeo Morimoto
Sadafumi Omura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2019935B3 publication Critical patent/ES2019935B3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungi isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/785—Mucor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/931—Mucor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES87303799T 1986-05-02 1987-04-29 Derivado de 14-hidroxieritromicina y metodo para obtenerlo. Expired - Lifetime ES2019935B3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61102881A JPH0633312B2 (ja) 1986-05-02 1986-05-02 １４−ハイドロキシエリスロマイシン誘導体およびその製造方法

Publications (1)

Publication Number Publication Date
ES2019935B3 true ES2019935B3 (es) 1991-07-16

Family

ID=14339213

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87303799T Expired - Lifetime ES2019935B3 (es) 1986-05-02 1987-04-29 Derivado de 14-hidroxieritromicina y metodo para obtenerlo.

Country Status (7)

Country Link
US (1) US4975370A (es)
EP (1) EP0245012B1 (es)
JP (1) JPH0633312B2 (es)
AT (1) ATE60783T1 (es)
DE (1) DE3767911D1 (es)
ES (1) ES2019935B3 (es)
GR (1) GR3001877T3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017632A (en) * 1989-12-14 1991-05-21 Rohm And Haas Company Water-based composites with superior cure in thick films, and chemical and shock resistance
CA2092045C (en) * 1992-03-19 2004-08-10 Setsuo Harada Erythromycin derivatives, preparation and use thereof
AU3533495A (en) * 1994-09-28 1996-04-19 Taisho Pharmaceutical Co., Ltd. Process for producing 12-hydroxy-6-0-alkylerythromycin and analogs thereof
US5804565A (en) * 1996-09-24 1998-09-08 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
US7435449B2 (en) 2004-12-20 2008-10-14 Tnemec Company, Inc. Waterborne epoxy coating composition and method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
JPS5849396A (ja) * 1981-09-07 1983-03-23 Toyo Jozo Co Ltd ４″−デオキシ−１４員環マクロライド抗生物質
US4672056A (en) * 1985-11-12 1987-06-09 Abbott Laboratories Erythromycin A derivatives and method of use

Also Published As

Publication number Publication date
EP0245012A1 (en) 1987-11-11
GR3001877T3 (en) 1992-11-23
JPS62263196A (ja) 1987-11-16
ATE60783T1 (de) 1991-02-15
US4975370A (en) 1990-12-04
EP0245012B1 (en) 1991-02-06
JPH0633312B2 (ja) 1994-05-02
DE3767911D1 (de) 1991-03-14

Similar Documents

Publication Publication Date Title
FR2606771B1 (fr) Procede d'hydroformylation utilisant des ligands phosphiniques peu volatils
DE3584788D1 (de) Laser-aufzeichnungssatz und verfahren zur herstellung.
DE3587519D1 (de) Verfahren zur herstellung von l-aminosaeuren.
ATA292885A (de) Verfahren zur herstellung von diphosphonsaeuren
DE3585471D1 (de) Verfahren zur herstellung einer matrize fuer eine aufzeichnungsplatte.
ATA253389A (de) Verfahren zur herstellung einer lagergleitschicht
DE3582869D1 (de) Photoaetzverfahren zur herstellung von chirurgischen naehnadeln.
DE3578807D1 (de) Verfahren zur herstellung von waermeempfindlichen aufzeichnungsmaterialien.
DE3682253D1 (de) Verfahren zur herstellung von arylpiperidinestern.
DE3584989D1 (de) Laser-aufzeichnungssatz und verfahren zur herstellung.
ES2019935B3 (es) Derivado de 14-hidroxieritromicina y metodo para obtenerlo.
ATE36528T1 (de) Verfahren zur herstellung von lagerstabilen benzothiazolsulfenamiden.
DK352384D0 (da) Plantevaekstmedium
DE3670169D1 (de) Verfahren zur herstellung von aufzeichnungsplatten.
DE3781749D1 (de) Herstellungsverfahren von optisch aktiven alkoholen.
DE3682821D1 (de) Verfahren zur herstellung eines hypoallergenischen moosoeles.
DE3677838D1 (de) Verfahren zur herstellung von alkylestern von 3,4-epoxybuttersaeure.
DE3676236D1 (de) Verfahren zur stabilisierung von mercaptobenzothiazol in einer schmieroelzusammensetzung.
ATA3486A (de) Verfahren zur herstellung von 1-(2-(5hu850111104/85
DE3764572D1 (de) Verfahren zur herstellung von 2.2-bis-(4-hydroxy-3-nitrophenyl)-hexafluorpropan.
AT386973B (de) Verfahren zur herstellung von wendemessern
DE3680121D1 (de) Verfahren zur herstellung von optisch aktiven glycerol-derivaten.
IT8720360A0 (it) Metodo per prevenire l'appannamento di superfici.
DE3586741D1 (de) Verfahren zur herstellung von 5'-guanylsaeure.
ATA180785A (de) Verfahren zur herstellung von oxazino-(5,6-c)-1,2-benzothiazin-6,6-dioxid